Company Description By 2050, the planet could be using twice as much electricity compared to today. Are you interested in contributing and helping to shape the future of the world’s energy? If so, read on. Fusion,
Company Description By 2050, the planet could be using twice as much electricity compared to today. Are you interested in contributing and helping to shape the future of the world’s energy? If so, read on. Fusion,
Company Description By 2050, the planet could be using twice as much electricity compared to today. Are you interested in contributing and helping to shape the future of the world’s energy? If so, read on. Fusion,
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet